[Edaily Reporter Kim Saemi] #BioPlus announced on the 18th that it has signed an overseas exclusive distribution agreement with JD Bio for its hyaluronic acid (HA) filler product line.

Under this agreement, JD Bio will be responsible for the overseas distribution and sales of BioPlus’s HA filler products. The two companies plan to collaborate to enter new markets and expand their sales networks.

JD Bio is a company that distributes medical aesthetic products such as fillers, botulinum toxin, and skin boosters. It supplies products to approximately 50 countries, including Europe, Southeast Asia, and Central and South America.

J-Bio serves as a global distribution partner for domestic and international medical beauty brands. Recently, it participated as the main sponsor of “AMWC Korea,” an academic conference on aesthetics and anti-aging.

BioPlus develops and manufactures HA filler products based on its proprietary MDM technology for cross-linking hyaluronic acid.

BioPlus is currently working to expand sales of its HA fillers in the Brazilian market. With this agreement, the company plans to expand its distribution channels to markets in Central and South America, as well as Europe and Asia.

Yoon Min-ho, Head of BioPlus, stated, “JD Bio is a partner with global distribution experience and an overseas sales network,” adding, “Through this collaboration, we will diversify our overseas sales base and enhance brand awareness.”